Intraprostatic Botulinum Toxin Type A injection in patients with benign prostatic enlargement: duration of the effect of a single treatment.

BMC Urol · 2009 · PMC2734751 · PMID 19682392

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

did not reach statistical significancep = 0,09so close (0.05 < p ≤ 0.1)

However these changes did not reach statistical significance (p = 0,09 and p = 0,16, respectively) At last observation mean value was 5,9 ± 1,6 ng/ml (p = 0,47).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.